rs35141404

Positions:

chr10-110644544-G-A

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001134363.3(RBM20):c.90G>A(p.Arg30=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.157 in 1,526,416 control chromosomes in the GnomAD database, including 21,086 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.20 ( 3977 hom., cov: 32)

Exomes 𝑓: 0.15 ( 17109 hom. )

Consequence

RBM20
NM_001134363.3 synonymous

Scores

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:14

Conservation

PhyloP100: 0.140

Variant links:

Genes affected

RBM20 (HGNC:27424): (RNA binding motif protein 20) This gene encodes a protein that binds RNA and regulates splicing. Mutations in this gene have been associated with familial dilated cardiomyopathy. [provided by RefSeq, Apr 2014]

RBM20 links:

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4

Computational evidence support a benign effect (BayesDel_noAF=-0.7).

BP6

Variant 10-110644544-G-A is Benign according to our data. Variant chr10-110644544-G-A is described in ClinVar as [Benign]. Clinvar id is 44029.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-110644544-G-A is described in Lovd as [Benign].

BP7

Synonymous conserved (PhyloP=0.14 with no splicing effect.

BA1

GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.365 is higher than 0.05.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	MANE	UniProt
RBM20	NM_001134363.3 linkuse as main transcript	c.90G>A	p.Arg30=	synonymous_variant	1/14	ENST00000369519.4
RBM20	XM_017016103.3 linkuse as main transcript	c.26+1104G>A		intron_variant

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	TSL	MANE	Appris	UniProt
RBM20	ENST00000369519.4 linkuse as main transcript	c.90G>A	p.Arg30=	synonymous_variant	1/14	1	NM_001134363.3	P1

Frequencies

GnomAD3 genomes

AF:

0.204

AC:

30937

AN:

151750

Hom.:

3968

Cov.:

show subpopulations

Gnomad AFR

AF:

0.370

Gnomad AMI

AF:

0.111

Gnomad AMR

AF:

0.148

Gnomad ASJ

AF:

0.103

Gnomad EAS

AF:

0.161

Gnomad SAS

AF:

0.143

Gnomad FIN

AF:

0.0971

Gnomad MID

AF:

0.149

Gnomad NFE

AF:

0.147

Gnomad OTH

AF:

0.189

GnomAD3 exomes

AF:

0.143

AC:

17277

AN:

120516

Hom.:

1440

AF XY:

0.144

AC XY:

9593

AN XY:

66524

show subpopulations

Gnomad AFR exome

AF:

0.412

Gnomad AMR exome

AF:

0.103

Gnomad ASJ exome

AF:

0.106

Gnomad EAS exome

AF:

0.168

Gnomad SAS exome

AF:

0.145

Gnomad FIN exome

AF:

0.102

Gnomad NFE exome

AF:

0.150

Gnomad OTH exome

AF:

0.149

GnomAD4 exome

AF:

0.152

AC:

208355

AN:

1374558

Hom.:

17109

Cov.:

AF XY:

0.151

AC XY:

102151

AN XY:

677954

show subpopulations

Gnomad4 AFR exome

AF:

0.388

Gnomad4 AMR exome

AF:

0.108

Gnomad4 ASJ exome

AF:

0.101

Gnomad4 EAS exome

AF:

0.186

Gnomad4 SAS exome

AF:

0.146

Gnomad4 FIN exome

AF:

0.0959

Gnomad4 NFE exome

AF:

0.149

Gnomad4 OTH exome

AF:

0.153

GnomAD4 genome

AF:

0.204

AC:

30977

AN:

151858

Hom.:

3977

Cov.:

AF XY:

0.199

AC XY:

14787

AN XY:

74196

show subpopulations

Gnomad4 AFR

AF:

0.370

Gnomad4 AMR

AF:

0.148

Gnomad4 ASJ

AF:

0.103

Gnomad4 EAS

AF:

0.161

Gnomad4 SAS

AF:

0.141

Gnomad4 FIN

AF:

0.0971

Gnomad4 NFE

AF:

0.147

Gnomad4 OTH

AF:

0.191

Alfa

AF:

0.157

Hom.:

541

Bravo

AF:

0.215

Asia WGS

AF:

0.186

AC:

647

AN:

3470

ClinVar

Significance: Benign

Submissions summary: Benign:14

Revision: criteria provided, multiple submitters, no conflicts

LINK: link

Submissions by phenotype

not specified

Benign:9

Benign, no assertion criteria provided	clinical testing	Clinical Genetics, Academic Medical Center	-	- -
Benign, criteria provided, single submitter	clinical testing	Eurofins Ntd Llc (ga)	Jun 16, 2016	- -
Benign, criteria provided, single submitter	clinical testing	Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute	Feb 23, 2017	- -
Benign, no assertion criteria provided	clinical testing	Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+	-	- -
Benign, criteria provided, single submitter	clinical testing	Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine	Sep 30, 2011	- -
Benign, no assertion criteria provided	clinical testing	Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center	-	- -
Benign, criteria provided, single submitter	clinical testing	PreventionGenetics, part of Exact Sciences	-	- -
Benign, criteria provided, single submitter	clinical testing	GeneDx	Nov 07, 2012	This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, no assertion criteria provided	clinical testing	Genome Diagnostics Laboratory, University Medical Center Utrecht	-	- -

Dilated cardiomyopathy 1DD

Benign:2

Benign, criteria provided, single submitter	clinical testing	Illumina Laboratory Services, Illumina	Jan 13, 2018	This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, criteria provided, single submitter	clinical testing	Invitae	Feb 01, 2024	- -

Cardiomyopathy

Benign:1

Benign, criteria provided, single submitter

clinical testing

CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario

Nov 10, 2015

- -

Primary dilated cardiomyopathy

Benign:1

Benign, no assertion criteria provided

clinical testing

Cohesion Phenomics

Sep 27, 2022

- -

Cardiovascular phenotype

Benign:1

Benign, criteria provided, single submitter

clinical testing

Ambry Genetics

Jun 24, 2015

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name

Calibrated prediction

Score

Prediction

BayesDel_noAF

Benign

-0.70

CADD

Benign

DANN

Benign

0.93

Splicing

Name

Calibrated prediction

Score

Prediction

SpliceAI score (max)

0.0

Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Variant summary

Frequency

Consequence

Scores

Clinical Significance

Conservation

ACMG classification

Transcripts

RefSeq

Ensembl

Frequencies

ClinVar

Submissions by phenotype

Computational scores

Splicing

Publications

LitVar

Other links and lift over